SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 11/15/2017 11/15/2017
Abstract: 8-K filed by Procter & Gamble Co. (PG) covering Regulation FD Disclosure and Financial Statements and Exhibits.
11-K 11-K 11/13/2017 6/30/2017
Abstract: Registrant filed the annual report for its savings plan.
11-K 11-K 11/6/2017 6/30/2017
Abstract: Registrant filed the annual report for its profit-sharing retirement plan.
Registration Statement 8-A12B 11/3/2017
Abstract: Registrant filed a description of its 4.125% EUR notes due December 2020, among other securities, in order to register them under the Securities Exchange Act of 1934.
8-K 8-K 10/25/2017 10/25/2017
Abstract: Registrant reported that on Oct. 25, it closed an underwritten public offering of $600 million of 1.750% notes due Oct. 25, 2019; $600 million of 1.900% notes due Oct. 23, 2020; and $600 million of 3.500% notes due Oct. 25, 2047, under the registrant’s registration statement on Form S-3. The opinions and consents of Hatsuki Miyata and Fried, Frank, Harris, Shriver & Jacobson LLP were included by exhibit.
8-K 8-K 10/25/2017 10/25/2017
Abstract: Registrant reported that on Oct. 25, it closed an underwritten public offering of €500 million of 0.500% notes due Oct. 25, 2024, and €500 million of 1.250% notes due Oct. 25, 2029, under the registrant’s registration statement on Form S-3. The opinions and consents of Hatsuki Miyata and Fried, Frank, Harris, Shriver & Jacobson LLP were included by exhibit.
Registration Statement 8-A12B 10/25/2017
Abstract: Registrant filed a description of its 0.500% notes due 2024 and 1.250% notes due 2029, incorporated by reference into its registration statement on Form S-3, in order to register them under the Securities Exchange Act of 1934.
Prospectus 424B5 10/24/2017
Prospectus 424B5 10/24/2017
Prospectus FWP 10/23/2017
Prospectus 424B5 10/23/2017
Prospectus 424B5 10/23/2017
Prospectus FWP 10/23/2017
8-K 8-K 10/20/2017 10/20/2017
Abstract: 8-K filed by Procter & Gamble Co. (PG) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 10/20/2017 10/20/2017
Abstract: 8-K filed by Procter & Gamble Co. (PG) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q 10-Q 10/20/2017 9/30/2017
Registration Statement S-3ASR 10/20/2017
Abstract: Registrant filed a registration statement for up to 14.5 million shares of common stock in an offering valued at approximately $1.34 billion offered through its direct stock purchase plan.
Registration Statement S-3ASR 10/20/2017
Abstract: Registrant filed a registration statement for up to 100,000 shares of common stock in an offering valued at approximately $9.3 million offered through the Procter & Gamble U.K. share investment scheme.
Registration Statement S-3ASR 10/20/2017
Abstract: Registrant filed a registration statement for an unspecified amount of debt securities. Proceeds from the offering will be used for general corporate purposes.
8-K 8-K 10/16/2017 10/10/2017
Abstract: 8-K filed by Procter & Gamble Co. (PG) covering Submission of Matters to a Vote of Security Holder.

Displaying 1 to 20 (of 537 filings)